April 20, 2007
FROM DR. KELCH'S NEWSLETTER TO FACULTY AND STAFF:
Regents approve build-out of Kellogg research space
This week the Regents approved revising the scope and budget of the Kellogg Eye Center Expansion Project to complete about 25,000 gross square feet of shelled research space to be used by the Department of Ophthalmology and Visual Sciences and the Brehm Center for Type I Diabetes Research. In total, the $132 million project provides 230,000 gross square feet for research, education and clinical facilities.
The expansion is moving along at a brisk pace. Excavation continues and the concrete foundation is being poured on the south side of the building.
When Kellogg clinicians, researchers and staff look at the “hole in the ground,” they see much more: modern clinics to bring advanced eye care to patients; facilities to enhance the education of future vision scientists and ophthalmologists; and expanded laboratory pace to build on successes in vision research.
For example, imagine that one day we could transplant cells that are essential for sight into the human retina to restore visual function. Kellogg scientists, led by Anand Swaroop, Ph.D., have just succeeded in a first significant step in transplantation using animal models. The new space will allow them to devote additional resources to this breakthrough and other emerging concepts. Read more: www.med.umich.edu/opm/newspage/2006/photoreceptor.htm.
Or consider retinal diseases like age-related macular degeneration, which causes gradual loss of central vision and affects the ability to read, drive and even recognize faces. Since 1996, Kellogg has seen a 67 percent increase in the number of patients with AMD - a trend that is occurring nationwide as the population ages. As a result, researchers and clinicians are directing some of their most concentrated efforts toward AMD. Kellogg has been involved in clinical trials for new drugs that have shown remarkable results in treating patients with "wet" AMD, the less common, but typically more damaging, form of the disease. One major focus of the new center will be to treat and cure all forms of AMD, as well as help all patients, young and old, who suffer from eye diseases such as glaucoma, cataract, ocular melanoma and diabetes-related eye disease.
At a time of rapid scientific discovery, this expansion will help U-M stay at the forefront of research and clinical practice in ophthalmology and vision science. Read more about the Kellogg Eye Cente expansion project: www.kellogg.umich.edu/expansion. Read more about the Brehm Center for Type I Diabetes Research: http://www.med.umich.edu/diabetes/brehmcenter/.